近日，在关中海关，西安瑟福能源科技有限公司工作人员为一批出口越南的可充电锂离子电池申办 了RCEP（《区域全面经济伙伴关系协定》）原产地证书。这批货值21万元的产品凭着这张证书，在越 南直接享受到1.1万元的关税免除，实打实省了一笔钱。 "2025年，公司对越南的锂离子电池出口量大幅增长。"2月9日，西安瑟福能源科技有限公司关务主 管谢子燕说，"关中海关常给我们讲RCEP原产地规则、关税减让等政策，让我们更加了解贸易形 势，'走出去'的底气更足了。" 2025年，关中海关为该企业出口可充电锂离子电池、聚合物锂离子电池签发了25份RCEP原产地证 书，货值近600万元，帮助企业累计获得外方关税减让30余万元。 "海关的智能审核和自助打印太方便了。以前申领RCEP原产地证书，得跑海关现场打印、盖章、签 字，需要两天时间。现在智能审核实现了证书'秒审'，在家就能自助打印，拿证快多了，给我们出口锂 电池帮了大忙。"谢子燕说。 西安瑟福能源科技有限公司的案例是陕西企业借力RCEP政策开拓海外市场的生动缩影。2026年1月 1日，RCEP迎来生效四周年。4年间，西安海关以精准服务为抓手，全力推动RCEP关税减让红利直达 ...

Core Insights - The report focuses on batteries used in implantable medical devices, highlighting lithium-ion batteries as a crucial type for devices like pacemakers and neurostimulators [2] - The global sales volume of these batteries is projected to reach approximately 108.04 MWh by 2025, with a unit price of about $3.26 per Wh [2] - The industry average gross margin is around 41%, benefiting from high certification barriers and long supply cycles [2] Market Overview - The global market for implantable device batteries is expected to reach $590 million by 2031 [3] - In 2025, the top ten manufacturers are estimated to hold about 71.4% of the market share [6] - The primary product type, Vanadium Oxide (Li/CFₓ–SVO), accounts for approximately 53.8% of the market share [8] - Minimally invasive/subcutaneous devices represent the largest application segment, capturing about 33.6% of the market [10] Industry Drivers and Challenges - Key drivers include the growing demand for chronic disease management and precision medicine, expanding applications in cardiac management and neurostimulation [14] - Challenges include high regulatory barriers, long clinical validation cycles, and the need for long-term biocompatibility and low failure rates [14] Development Opportunities - Opportunities exist in the parallel evolution of high energy density primary and rechargeable battery systems, as well as advancements in wireless charging and energy harvesting technologies [15] - The aging population and increased penetration of home healthcare are expected to create a broader development space for battery companies with material innovation capabilities [15] Leading Companies - Major manufacturers in the global implantable device battery market include EnerSys, Abbott Labs, Boston Scientific, Medtronic, Panasonic, and others [5] - EnerSys has a long history and has evolved into a global industrial technology company, providing energy storage solutions across various sectors [16]

Core Viewpoint - The article discusses a significant safety crisis in the power bank industry triggered by the recall of defective battery cells, highlighting the role of specific suppliers and the implications for various brands in the market [1][2]. Group 1: Recall and Supplier Issues - The recall of power banks is primarily due to defective battery cells, with companies like Romoss and Anker citing "material issues" from suppliers [1]. - Anker's production partner, Anker Innovations, confirmed that certain batches of industry-standard battery cells had unauthorized material changes [1]. - The specific supplier linked to the recalled Anker A1681 power bank is identified as Amperes (Wuxi) Co., Ltd., which has faced regulatory scrutiny and has had multiple certifications suspended due to factory inspection failures [1][2]. Group 2: Industry Context and Competition - The power bank industry is characterized by intense competition and a prevalent OEM (Original Equipment Manufacturer) model, leading to low profit margins for manufacturers [3]. - Battery cells account for 40%-50% of the total cost of a power bank, making them a critical component where cost-cutting measures may compromise quality [3]. - The production of battery cells requires significant technical expertise and investment, indicating that issues with battery cells can have widespread repercussions across multiple brands [3]. Group 3: Company Background - Amperes (Wuxi) Co., Ltd. is a prominent soft-pack battery cell manufacturer in China, established in 2014 with a total investment of $200 million [4]. - As of 2023, Amperes has produced over 100 million lithium batteries and supplies battery cells to various brands, including Anker, Romoss, Xiaomi, and others [4]. - The recalls involve significant quantities, with Romoss recalling 490,000 units and Anker recalling 710,000 units [4].